Current Funding Opportunities
Click here to visit the NCI grant site.
Use your device's search function to find a specific disease or funding source.
- External Funding
- Internal Grant Opportunities
Funding
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP).
The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards
- Established Investigator Awards
Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis.
Learn More>>
Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01)
This FOA encourages research projects that focus on innovative research in the isolation and characterization of extracellular vesicles (EVs) and their cargo for discovery of predictive biomarkers for risk assessment, detection, diagnosis and prognosis of early cancer.
Application Deadline: February 5, 2020
Learn more about analytes for cancer detection program>>Leukemia Research Foundation: Hollis Brown New Investigator Research Grants Program
The Leukemia Research Foundation exclusively funds New Investigator grants for blood cancer research projects that focus on leukemia, lymphoma, multiple myeloma, and/or MDS.
Letter of Intent Due: February 7, 2020
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21)
This FOA solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care.
Application Deadline: February 21, 2020
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-019.html
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21)
This FOA solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research.
Application Deadline: February 21, 2020
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-017.html
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33)
This FOA solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies that improve the quality of the samples used for cancer research or clinical care.
Application Deadline: February 21, 2020
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-020.html
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)
This FOA solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research.
Application Deadline: February 21, 2020
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-018.html
NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022
This FOA supports small research projects on cancer that can be carried out in a short period of time with limited resources.
Application Deadline: February 24, 2020
Learn more about NCI small grants program>>
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00)
The purpose of the NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Fellows (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators.
Application Deadline: February 26, 2020
Learn more about NCI Pathway to Independence Award>>Human Health Exposure Analysis Resource (HHEAR)
The HHEAR Program enables NCI-funded researchers to integrate environmental exposures into their existing studies by providing access to high-quality, exposure-assessment services, including: state of the art targeted laboratory analysis of biological samples; statistical analysis services; and expert consultation on exposure analysis, study design, and data analysis and interpretation.
Application Deadline: February 28, 2020
Learn more about the HHEAR award>>
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01)
The purpose of this FOA is to encourage revision applications (formerly called "competing revisions") from currently funded NCI R01 research projects. The applicants should propose projects that are expected to accelerate the pace of translation of NCI-supported methods/assays/technologies to the clinic.
Application Deadline: February 28, 2020
https://grants.nih.gov/grants/guide/pa-files/PAR-20-074.html
DoD Breast Cancer Research Program Funding Opportunities FY20
The FY20 Defense Appropriation Act is providing funding to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative, high-impact research with clinical relevance that will accelerate progress to end breast cancer for Service members, Veterans, and the general public.
- Breakthrough Award Levels 1 and 2 – Letter of Intent Due March 12, 2020
- Breakthrough Award Level 3 – Preproposal due March 13, 2020
- Breakthrough Award Level 4 – Preproposal due March 13, 2020
- Era of Hope Scholar Award – Letter of Intent due March 12, 2020
- Innovator Award – Preproposal due March 13, 2020
Co-infection and Cancer (R21 and R01)
The purpose of this FOA is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection.
Application Deadline (R21): March 17, 2020
Application Deadline (R01): March 6, 2020
Learn more about co-infection R21 and R01>>Methods and Measurement in Research with Sexual and Gender Minority (SGM) Populations (R21)
The purpose of this initiative is to support research projects to advance the measurement of constructs relevant to health research with sexual and gender minority (SGM) populations.
Application Deadline: March 13, 2020
Learn more about the SGM R21>>Sontag Foundation Distinguished Scientist Award
This award provides career and research support to early career scientists who demonstrate outstanding promise for making scientific and medical breakthroughs in the field of brain cancer research.
Application Deadline: March 16, 2020
Learn more about the Sontag Award>>Cancer Research Institute Postdoctoral Fellowship
The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology.
Application Deadline: April 1, 2020
Learn more about the CRI fellowship>>